| Dr Lance Anthony Bezzina, DO | |
|
1000 Langworthy St, Dubuque, IA 52001-7313 | |
| (563) 584-3445 | |
| (563) 584-3446 |
| Full Name | Dr Lance Anthony Bezzina |
|---|---|
| Gender | Male |
| Speciality | Thoracic Surgery |
| Experience | 19 Years |
| Location | 1000 Langworthy St, Dubuque, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275752511 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 4369 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bryan Medical Center | Lincoln, NE | Hospital |
| Great Plains Health | North platte, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Integrated Cardiology Group Llc | 7911803796 | 71 |
News Archive
In a review article published this month in The Oncologist, UNC's Dr. Richard M. Goldberg and a team of colleagues catalogue how the data collected in a single large comparative clinical trial testing combination chemotherapy for metastatic colorectal cancer has been used not only to benefit the patients that enrolled but also patients who subsequently developed the disease.
Actelion Pharmaceuticals US, Inc. and the ENTELLIGENCE Steering Committee recognized four young researchers and their mentors for their efforts in advancing research in PAH. Each researcher will receive a 12-month mentored grant of up to $100,000 in support, funded through the ENTELLIGENCE program supported by Actelion. The announcement was made at an awards luncheon, during which the recipients of the 2011 awards gave an overview of their proposed work.
Bayer HealthCare and the Drugs for Neglected Diseases initiative (DNDi) have signed an agreement under which Bayer will provide the active ingredient emodepside to support DNDi in its effort to develop a new oral drug to treat river blindness (or onchocerciasis). The world's second leading infectious cause of blindness, river blindness is a neglected tropical disease caused by a filarial worm.
A prospective, community-based study confirms that patients with epilepsy usually die of the same causes as other people.
At the 2019 American College of Rheumatology/Association of Rheumatology Professionals annual meeting in Atlanta, experts from the HSS Education Institute at Hospital for Special Surgery presented their method for developing and implementing effective educational programs for diverse patients with rheumatic conditions.
› Verified 5 days ago
| Entity Name | Integrated Cardiology Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982653515 PECOS PAC ID: 7911803796 Enrollment ID: O20031211000484 |
News Archive
In a review article published this month in The Oncologist, UNC's Dr. Richard M. Goldberg and a team of colleagues catalogue how the data collected in a single large comparative clinical trial testing combination chemotherapy for metastatic colorectal cancer has been used not only to benefit the patients that enrolled but also patients who subsequently developed the disease.
Actelion Pharmaceuticals US, Inc. and the ENTELLIGENCE Steering Committee recognized four young researchers and their mentors for their efforts in advancing research in PAH. Each researcher will receive a 12-month mentored grant of up to $100,000 in support, funded through the ENTELLIGENCE program supported by Actelion. The announcement was made at an awards luncheon, during which the recipients of the 2011 awards gave an overview of their proposed work.
Bayer HealthCare and the Drugs for Neglected Diseases initiative (DNDi) have signed an agreement under which Bayer will provide the active ingredient emodepside to support DNDi in its effort to develop a new oral drug to treat river blindness (or onchocerciasis). The world's second leading infectious cause of blindness, river blindness is a neglected tropical disease caused by a filarial worm.
A prospective, community-based study confirms that patients with epilepsy usually die of the same causes as other people.
At the 2019 American College of Rheumatology/Association of Rheumatology Professionals annual meeting in Atlanta, experts from the HSS Education Institute at Hospital for Special Surgery presented their method for developing and implementing effective educational programs for diverse patients with rheumatic conditions.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lance Anthony Bezzina, DO 1500 Associates Dr, Dubuque, IA 52002-2201 Ph: (563) 584-4100 | Dr Lance Anthony Bezzina, DO 1000 Langworthy St, Dubuque, IA 52001-7313 Ph: (563) 584-3445 |
News Archive
In a review article published this month in The Oncologist, UNC's Dr. Richard M. Goldberg and a team of colleagues catalogue how the data collected in a single large comparative clinical trial testing combination chemotherapy for metastatic colorectal cancer has been used not only to benefit the patients that enrolled but also patients who subsequently developed the disease.
Actelion Pharmaceuticals US, Inc. and the ENTELLIGENCE Steering Committee recognized four young researchers and their mentors for their efforts in advancing research in PAH. Each researcher will receive a 12-month mentored grant of up to $100,000 in support, funded through the ENTELLIGENCE program supported by Actelion. The announcement was made at an awards luncheon, during which the recipients of the 2011 awards gave an overview of their proposed work.
Bayer HealthCare and the Drugs for Neglected Diseases initiative (DNDi) have signed an agreement under which Bayer will provide the active ingredient emodepside to support DNDi in its effort to develop a new oral drug to treat river blindness (or onchocerciasis). The world's second leading infectious cause of blindness, river blindness is a neglected tropical disease caused by a filarial worm.
A prospective, community-based study confirms that patients with epilepsy usually die of the same causes as other people.
At the 2019 American College of Rheumatology/Association of Rheumatology Professionals annual meeting in Atlanta, experts from the HSS Education Institute at Hospital for Special Surgery presented their method for developing and implementing effective educational programs for diverse patients with rheumatic conditions.
› Verified 5 days ago
Warren Edward Gall, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 1000 Langworthy St, Dubuque, IA 52001 Phone: 563-584-3445 Fax: 563-584-3497 | |
Dr. Sinan Ali Simsir, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1000 Langworthy St, Dubuque, IA 52001 Phone: 563-584-3445 Fax: 563-584-3446 |